生物製剤検査の世界市場レポート 2025年

生物製剤検査の市場規模は今後数年で急成長が見込まれます。2029年にはCAGR17.2％で129億1,000万米ドルに成長します。予測期間の成長は、先進治療の登場、受託検査サービス需要の増加、生物製剤パイプラインの拡大、バイオ医薬品製造のグローバル化、迅速検査ソリューションの需要増加などに起因します。予測期間における主な動向には、高度な分析技術、細胞ベースアッセイ、次世代シーケンシング（NGS）、クオリティバイデザイン（QBD）原則、人工知能（AI）の統合、製品リリースの迅速化などが含まれます。

急速に拡大する製薬・バイオテクノロジー分野は、今後の生物製剤検査市場の成長を大きく後押しすると予想されます。製薬業界は主に、さまざまな疾患や病状に対応する医薬品の開発と生産に重点を置いており、バイオテクノロジー分野は生物学やヘルスケアにおける技術の応用に重点を置いています。生物製剤検査には、不純物の同定と定量化、薬物の安定性の評価、薬物に対する免疫反応の評価などを目的とした検査が含まれます。これらの産業の成長は、新しい分析ツールやテクニックの開発など、生物製剤検査技術の進歩にも拍車をかけています。これらの技術革新は、より正確で効率的な試験プロセスを促進し、新しい生物製剤の上市にかかる時間とコストを削減しています。例えば、ベルギーを拠点とする管理機関ユーロスタットの報告書によると、EUにおける医薬品生産額は2021年の360億ユーロ（約394億米ドル）から2023年には440億ユーロ（約467億米ドル）に増加し、この分野の大幅な成長を示しています。その結果、製薬およびバイオテクノロジー産業の急速な拡大が生物製剤検査市場の成長を牽引しています。

生物製剤検査市場の成長予測は、生物製剤の安全性、有効性、革新性を促進する極めて重要な触媒である研究開発における政府のイニシアチブの高まりによってさらに促進されます。政府のイニシアチブは生物製剤検査の様々な側面を網羅し、強力な支援プログラムを通じて安全性と有効性を保証しています。ホワイトハウスの2023年大統領予算における研究開発への2,049億米ドルの大幅な資金配分は、このようなコミットメントを反映したものであり、2021年レベルから28％の増加となっています。このようなイニシアチブは、技術革新の育成と研究の推進により、生物製剤検査市場の成長に大きく貢献します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の生物製剤検査市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の生物製剤検査市場：成長率分析
• 世界の生物製剤検査市場の実績：規模と成長、2019～2024年
• 世界の生物製剤検査市場の予測：規模と成長、2024～2029年、2034年
• 世界の生物製剤検査総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の生物製剤検査市場：製品別、実績と予測、2019～2024年、2024～2029年、2034年
• 試薬・キット
• 機器
• その他
• 世界の生物製剤検査市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• エンドトキシン検査
• 無菌検査
• マイコプラズマ検査
• バイオバーデン検査
• 残留宿主細胞タンパク質およびDNA検出検査
• ウイルス安全性検査
• その他
• 世界の生物製剤検査市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• ワクチン開発と製造
• モノクローナル抗体開発と製造
• 細胞および遺伝子治療製品開発と製造
• 血液および血液製品開発と製造
• その他
• 世界の生物製剤検査市場：試薬・キットのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ELISAキット
• PCRキット
• 細胞培養試薬
• その他のアッセイキット
• 世界の生物製剤検査市場：機器のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 分光光度計
• クロマトグラフィーシステム
• マイクロプレートリーダー
• その他の分析機器
• 世界の生物製剤検査市場：その他のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ソフトウェア
• 消耗品
• 参照標準

第7章 地域別・国別分析

• 世界の生物製剤検査市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の生物製剤検査市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 生物製剤検査市場：競合情勢
• 生物製剤検査市場：企業プロファイル
  • Charles River Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • SGS Societe Generale de Surveillance SA Overview, Products and Services, Strategy and Financial Analysis
  • WuXi AppTec Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Sartorius AG
• Cytovance Biologics Inc.
• Pace Analytical Services Inc.
• Avance Biosciences Inc.
• Celgene Corporation
• Biomerieux SA
• Lonza Group Ltd.
• Genscript Biotech Corp.
• Bio-Rad Laboratories Inc.
• Accugen Laboratories Inc.
• Gibraltar Laboratories Inc.
• Jordi Labs
• Gilead Sciences Inc.
• Bioquell Limited
• Southern Research

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 生物製剤検査市場2029年：新たな機会を提供する国
• 生物製剤検査市場2029年：新たな機会を提供するセグメント
• 生物製剤検査市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Biologics testing encompasses a spectrum of services designed to assess the safety, effectiveness, and quality of biological products.

Within the realm of biologics testing, the primary products include reagents, kits, instruments, and other related items. Instruments, in this context, refer to tools, devices, or machines utilized for conducting experiments, analyzing data, or observing biological samples. The suite of tests involved in biologics testing spans various assessments such as endotoxin testing, sterility testing, mycoplasma testing, bioburden testing, residual detection of host-cell proteins and DNA, virus safety testing, and other specialized tests. These tests find applications across vaccine development and manufacturing, the development and manufacturing of monoclonal antibodies, cellular and gene therapy products, blood and blood products, and various other applications within the biologics industry.

The biologics testing market research report is one of a series of new reports from The Business Research Company that provides biologics testing optical components market statistics, including biologics testing optical components industry global market size, regional shares, competitors with a biologics testing optical components market share, detailed biologics testing optical components market segments, market trends and opportunities, and any further data you may need to thrive in the biologics testing optical components industry. This biologics testing optical components market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biologics testing market size has grown rapidly in recent years. It will grow from$5.92 billion in 2024 to $6.85 billion in 2025 at a compound annual growth rate (CAGR) of 15.7%. The growth in the historic period can be attributed to growth in biologics development, stringent regulatory standards, quality control in bioprocessing, rise in biopharmaceutical investments, expansion of biomanufacturing capacity

The biologics testing market size is expected to see rapid growth in the next few years. It will grow to $12.91 billion in 2029 at a compound annual growth rate (CAGR) of 17.2%. The growth in the forecast period can be attributed to emergence of advanced therapies, increasing demand for contract testing services, expansion of biologics pipelines, globalization of biopharmaceutical manufacturing, increasing demand for rapid testing solutions. Major trends in the forecast period include advanced analytical technologies, cell-based assays, next-generation sequencing (NGS), quality by design (QBD) principles, integration of artificial intelligence (AI), rapid methods for product release.

The swiftly expanding pharmaceutical and biotechnology sectors are expected to significantly boost the growth of the biologics testing market in the future. The pharmaceutical industry mainly focuses on the development and production of medications for a variety of diseases and medical conditions, while the biotechnology sector emphasizes the application of technology in biology and healthcare. Biologics testing encompasses tests designed to identify and quantify impurities, assess drug stability, and evaluate immune responses to medications. The growth of these industries has also spurred advancements in biologics testing technologies, including the creation of new analytical tools and techniques. These innovations have facilitated more accurate and efficient testing processes, thereby reducing the time and cost associated with bringing new biologics to market. For example, a report from Eurostat, a Belgium-based governing body, revealed that pharmaceutical production in the EU rose from €36 billion ($39.4 billion) in 2021 to €44 billion ($46.7 billion) in 2023, indicating substantial growth in the sector. Consequently, the rapid expansion of the pharmaceutical and biotechnology industries is driving the growth of the biologics testing market.

The projected growth of the biologics testing market is further fueled by rising government initiatives in research and development, a pivotal catalyst for advancing safety, effectiveness, and innovation in biologics. Government initiatives encompass various facets of biologics testing, ensuring safety and efficacy through robust support programs. The White House's substantial funding allocation of $204.9 billion for research and development in the President's 2023 budget reflects this commitment, representing a 28% increase from the 2021 level. These initiatives significantly contribute to the growth of the biologics testing market by nurturing innovation and advancing research.

A prominent trend in the biologics testing market is the focus on product innovations, with companies striving to introduce cutting-edge solutions to maintain their market positions. Noteworthy is Charles River Laboratories International, Inc.'s December 2022 launch of the Endosafe Nexus 200TM, a state-of-the-art instrument in their endotoxin testing line. This instrument, utilizing Endosafe Limulus Amebocyte Lysate (LAL) cartridge technology, streamlines processes for water, in-process, and final product testing, offering enhanced traceability, security, and data management.

Major companies in the biologics testing market are innovating with new technologies, such as protein engineering techniques, to enhance profitability. Queensland University of Technology's launch of a novel protein-engineering technique in July 2023 underscores this trend. This groundbreaking technology aims to expedite and refine the creation of diagnostic tests, promising significant positive impacts on both healthcare and the economy. Such innovations are instrumental in driving advancements within the biologics testing market, fostering growth and profitability.

In July 2022, Solvias Inc., a pharmaceutical testing and manufacturing firm based in the U.S., acquired Cergentis B.V. for an undisclosed sum. This acquisition is intended to strengthen Solvias's capabilities in biologics and cell and gene therapy (CGT) testing solutions, addressing the increasing demand in these areas. Cergentis B.V., located in the Netherlands, is a biotechnology company that specializes in offering innovative solutions in genomics and molecular biology.

Major companies operating in the biologics testing market include Charles River Laboratories Inc., Thermo Fisher Scientific Inc., Merck KGaA, SGS Societe Generale de Surveillance SA, WuXi AppTec Co. Ltd., Sartorius AG, Cytovance Biologics Inc., Pace Analytical Services Inc., Avance Biosciences Inc., Celgene Corporation, Biomerieux SA, Lonza Group Ltd., Genscript Biotech Corp., Bio-Rad Laboratories Inc., Accugen Laboratories Inc., Gibraltar Laboratories Inc., Jordi Labs, Gilead Sciences Inc., Bioquell Limited, Southern Research, Promega Corporation, Lancaster Laboratories Inc., Toxikon Corporation, Eurofins BioPharma Product Testing, Johnson & Johnson Inc., QIAGEN N.V., GlaxoSmithKline plc, Danaher Corporation, Agilent Technologies Inc., PerkinElmer Inc., Abbott Laboratories, Beckman Coulter Inc., Becton Dickinson and Company, Roche Holding AG, Novartis AG, Eli Lilly and Company, Pfizer Inc.

North America was the largest region in the biologics testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global biologics testing market duirng the forecast period. The regions covered in the biologics testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the biologics testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The biologics testing market includes revenues earned by entities by providing services such as potency testing, purity testing, sterility testing, immunogenicity testing and others. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biologics Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biologics testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biologics testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biologics testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Reagents And Kits; Instruments; Other Products
• 2) By Test Type: Endotoxin Test; Sterility Test; Mycoplasma Tests; Bioburden Tests; Residual Host-Cell Proteins And DNA Detection Tests; Virus Safety Test; Other Test Types
• 3) By Application: Vaccine Development And Manufacturing; Monoclonal Antibodies Development And Manufacturing; Cellular And Gene Therapy Products Development And Manufacturing; Blood And Blood Products Development And Manufacturing; Other Applications
• Subsegments:
• 1) By Reagents And Kits: ELISA Kits; PCR Kits; Cell Culture Reagents; Other Assay Kits
• 2) By Instruments: Spectrophotometers; Chromatography Systems; Microplate Readers; Other Analytical Instruments
• 3) By Other Products: Software; Consumables; Reference Standards
• Companies Mentioned: Charles River Laboratories Inc.; Thermo Fisher Scientific Inc.; Merck KGaA; SGS Societe Generale de Surveillance SA; WuXi AppTec Co. Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Biologics Testing Market Characteristics

3. Biologics Testing Market Trends And Strategies

4. Biologics Testing Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Biologics Testing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Biologics Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Biologics Testing Market Growth Rate Analysis
• 5.4. Global Biologics Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Biologics Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Biologics Testing Total Addressable Market (TAM)

6. Biologics Testing Market Segmentation

• 6.1. Global Biologics Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reagents And Kits
• Instruments
• Other Products
• 6.2. Global Biologics Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Endotoxin Test
• Sterility Test
• Mycoplasma Tests
• Bioburden Tests
• Residual Host-Cell Proteins And DNA Detection Tests
• Virus Safety Test
• Other Test Types
• 6.3. Global Biologics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vaccine Development And Manufacturing
• Monoclonal Antibodies Development And Manufacturing
• Cellular And Gene Therapy Products Development And Manufacturing
• Blood And Blood Products Development And Manufacturing
• Other Applications
• 6.4. Global Biologics Testing Market, Sub-Segmentation Of Reagents And Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• ELISA Kits
• PCR Kits
• Cell Culture Reagents
• Other Assay Kits
• 6.5. Global Biologics Testing Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Spectrophotometers
• Chromatography Systems
• Microplate Readers
• Other Analytical Instruments
• 6.6. Global Biologics Testing Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Software
• Consumables
• Reference Standards

7. Biologics Testing Market Regional And Country Analysis

• 7.1. Global Biologics Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Biologics Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Biologics Testing Market

• 8.1. Asia-Pacific Biologics Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Biologics Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Biologics Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Biologics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Biologics Testing Market

• 9.1. China Biologics Testing Market Overview
• 9.2. China Biologics Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Biologics Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Biologics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Biologics Testing Market

• 10.1. India Biologics Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Biologics Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Biologics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Biologics Testing Market

• 11.1. Japan Biologics Testing Market Overview
• 11.2. Japan Biologics Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Biologics Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Biologics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Biologics Testing Market

• 12.1. Australia Biologics Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Biologics Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Biologics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Biologics Testing Market

• 13.1. Indonesia Biologics Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Biologics Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Biologics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Biologics Testing Market

• 14.1. South Korea Biologics Testing Market Overview
• 14.2. South Korea Biologics Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Biologics Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Biologics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Biologics Testing Market

• 15.1. Western Europe Biologics Testing Market Overview
• 15.2. Western Europe Biologics Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Biologics Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Biologics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Biologics Testing Market

• 16.1. UK Biologics Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Biologics Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Biologics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Biologics Testing Market

• 17.1. Germany Biologics Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Biologics Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Biologics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Biologics Testing Market

• 18.1. France Biologics Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Biologics Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Biologics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Biologics Testing Market

• 19.1. Italy Biologics Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Biologics Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Biologics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Biologics Testing Market

• 20.1. Spain Biologics Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Biologics Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Biologics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Biologics Testing Market

• 21.1. Eastern Europe Biologics Testing Market Overview
• 21.2. Eastern Europe Biologics Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Biologics Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Biologics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Biologics Testing Market

• 22.1. Russia Biologics Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Biologics Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Biologics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Biologics Testing Market

• 23.1. North America Biologics Testing Market Overview
• 23.2. North America Biologics Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Biologics Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Biologics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Biologics Testing Market

• 24.1. USA Biologics Testing Market Overview
• 24.2. USA Biologics Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Biologics Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Biologics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Biologics Testing Market

• 25.1. Canada Biologics Testing Market Overview
• 25.2. Canada Biologics Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Biologics Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Biologics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Biologics Testing Market

• 26.1. South America Biologics Testing Market Overview
• 26.2. South America Biologics Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Biologics Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Biologics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Biologics Testing Market

• 27.1. Brazil Biologics Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Biologics Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Biologics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Biologics Testing Market

• 28.1. Middle East Biologics Testing Market Overview
• 28.2. Middle East Biologics Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Biologics Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Biologics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Biologics Testing Market

• 29.1. Africa Biologics Testing Market Overview
• 29.2. Africa Biologics Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Biologics Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Biologics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Biologics Testing Market Competitive Landscape And Company Profiles

• 30.1. Biologics Testing Market Competitive Landscape
• 30.2. Biologics Testing Market Company Profiles
  • 30.2.1. Charles River Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. SGS Societe Generale de Surveillance SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. WuXi AppTec Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Biologics Testing Market Other Major And Innovative Companies

• 31.1. Sartorius AG
• 31.2. Cytovance Biologics Inc.
• 31.3. Pace Analytical Services Inc.
• 31.4. Avance Biosciences Inc.
• 31.5. Celgene Corporation
• 31.6. Biomerieux SA
• 31.7. Lonza Group Ltd.
• 31.8. Genscript Biotech Corp.
• 31.9. Bio-Rad Laboratories Inc.
• 31.10. Accugen Laboratories Inc.
• 31.11. Gibraltar Laboratories Inc.
• 31.12. Jordi Labs
• 31.13. Gilead Sciences Inc.
• 31.14. Bioquell Limited
• 31.15. Southern Research

32. Global Biologics Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biologics Testing Market

34. Recent Developments In The Biologics Testing Market

35. Biologics Testing Market High Potential Countries, Segments and Strategies

• 35.1 Biologics Testing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Biologics Testing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Biologics Testing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer